212 related articles for article (PubMed ID: 25201844)
1. Hand and foot syndrome secondary to capecitabine.
Lal HS
Indian J Dermatol Venereol Leprol; 2014; 80(5):427-30. PubMed ID: 25201844
[TBL] [Abstract][Full Text] [Related]
2. [Capecitabine-induced hyperpigmentation].
Vázquez-Bayo C; Rodríguez-Bujaldón AL; Jiménez-Puya R; Galán-Gutiérrez M; Moreno-Giménez JC
Actas Dermosifiliogr; 2007 Sep; 98(7):491-3. PubMed ID: 17669305
[TBL] [Abstract][Full Text] [Related]
3. [A woman with palmar and plantar hyperpigmentation].
van Tienhoven G; Wilmink JW
Ned Tijdschr Geneeskd; 2011; 155(45):A4100. PubMed ID: 22085578
[TBL] [Abstract][Full Text] [Related]
4. Management of hand-foot syndrome in patients treated with capecitabine (Xeloda).
Lassere Y; Hoff P
Eur J Oncol Nurs; 2004; 8 Suppl 1():S31-40. PubMed ID: 15341880
[TBL] [Abstract][Full Text] [Related]
5. [A case of severe hand-foot syndrome caused by capecitabine].
Shimomatsuya T; Mitsudou Y; Nakamura T; Yonezawa K; Shiraishi S; Fujino M; Maruhashi K
Gan To Kagaku Ryoho; 2007 Jul; 34(7):1139-41. PubMed ID: 17637558
[TBL] [Abstract][Full Text] [Related]
6. Capecitabine-induced diffuse palmoplantar keratoderma: is it a sequential event of hand-foot syndrome?
Do JE; Kim YC
Clin Exp Dermatol; 2007 Sep; 32(5):519-21. PubMed ID: 17509060
[TBL] [Abstract][Full Text] [Related]
7. Hand-foot syndrome variant in a dihydropyrimidine dehydrogenase-deficient patient treated with capecitabine.
Saif MW; Elfiky A; Diasio R
Clin Colorectal Cancer; 2006 Sep; 6(3):219-23. PubMed ID: 17026792
[TBL] [Abstract][Full Text] [Related]
8. Increased mast cell density in capecitabine-induced hand-foot syndrome: a new pathologic finding.
Latif S; Fraga G; Gadzia J
J Drugs Dermatol; 2010 Mar; 9(3):268-70. PubMed ID: 20232590
[TBL] [Abstract][Full Text] [Related]
9. Management of hand-foot syndrome induced by capecitabine.
Gressett SM; Stanford BL; Hardwicke F
J Oncol Pharm Pract; 2006 Sep; 12(3):131-41. PubMed ID: 17022868
[TBL] [Abstract][Full Text] [Related]
10. Capecitabine-induced hand-foot syndrome and cutaneous hyperpigmentation in an elderly vitiligo patient.
Tavares-Bello R
J Eur Acad Dermatol Venereol; 2007 Nov; 21(10):1434-5. PubMed ID: 17958867
[No Abstract] [Full Text] [Related]
11. [Capecitabine-induced hyperpigmentation followed by hand-foot syndrome: a new case report].
Agharbi FZ; Meziane M; Benhemmne H; Daoudi K; Elmesbahi O; Mikou O; Mernissi FZ
Ann Dermatol Venereol; 2012 Mar; 139(3):221-2. PubMed ID: 22401689
[No Abstract] [Full Text] [Related]
12. Serious hand-and-foot syndrome in black patients treated with capecitabine: report of 3 cases and review of the literature.
Narasimhan P; Narasimhan S; Hitti IF; Rachita M
Cutis; 2004 Feb; 73(2):101-6. PubMed ID: 15027515
[TBL] [Abstract][Full Text] [Related]
13. Hand-foot syndrome with scleroderma-like change induced by the oral capecitabine: a case report.
Lee SD; Kim HJ; Hwang SJ; Kim YJ; Nam SH; Kim BS
Korean J Intern Med; 2007 Jun; 22(2):109-12. PubMed ID: 17616027
[TBL] [Abstract][Full Text] [Related]
14. Palmar-plantar hyperpigmentation with capecitabine in adjuvant colon cancer.
Vickers MM; Easaw JC
J Gastrointest Cancer; 2008; 39(1-4):141-3. PubMed ID: 19440857
[TBL] [Abstract][Full Text] [Related]
15. Onycholysis with the appearance of a "sunset" secondary to capecitabine.
Maino KL; Norwood C; Stashower ME
Cutis; 2003 Sep; 72(3):234-6. PubMed ID: 14533836
[TBL] [Abstract][Full Text] [Related]
16. Capecitabine and PPE syndrome: a case report.
LoRusso PM
Breast J; 2003; 9(1):64-5. PubMed ID: 12558679
[No Abstract] [Full Text] [Related]
17. [Progress of study on prevention and treatment of xeloda induced hand-foot syndrome by measures of Chinese and Western medicine].
Wang Y; Xu RR
Zhongguo Zhong Xi Yi Jie He Za Zhi; 2007 Feb; 27(2):182-4. PubMed ID: 17343012
[TBL] [Abstract][Full Text] [Related]
18. Unilateral hand-foot syndrome: an extraordinary side effect of capecitabine.
Disel U; Gürkut O; Abali H; Kaleağasi H; Mertsoylu H; Ozyilkan O; Saif MW
Cutan Ocul Toxicol; 2010 Jun; 29(2):140-2. PubMed ID: 20298142
[TBL] [Abstract][Full Text] [Related]
19. Is pyridoxine helpful in preventing palmar-plantar erythrodysesthesia associated with capecitabine?
Jeung HC; Chung HC
Asia Pac J Clin Oncol; 2010 Sep; 6(3):141-3. PubMed ID: 20887492
[No Abstract] [Full Text] [Related]
20. [Hand-foot syndrome with capecitabine therapy].
Marini A; Hengge UR
Hautarzt; 2007 Jun; 58(6):532-6. PubMed ID: 16897045
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]